@article{lemaitre:hal-03481137,
TITLE = {Has the Time Come for Systematic Therapeutic Drug Monitoring of First-line and WHO Group A Anti-tuberculosis Drugs?},
AUTHOR = {Lemaitre, Florian},
URL = {https://hal.science/hal-03481137},
JOURNAL = {Therapeutic Drug Monitoring},
PUBLISHER = {Lippincott, Williams \& Wilkins},
VOLUME = {44},
NUMBER = {1},
PAGES = {133-137},
YEAR = {2022},
MONTH = Feb, DOI = {10.1097/FTD.0000000000000948},
KEYWORDS = {antituberculous ; pharmacokinetics ; pharmacodynamics ; exposure ; rifampicin ; isoniazid ; ethambutol ; pyrazinamide ; fluoroquinolones ; linezolid ; bedaquiline},
PDF = {https://hal.science/hal-03481137/file/Lemaitre-2022-Has%20the%20time%20come%20for%20systematic%20therapeutic%20drug%20monitoring%20of%20first-line%20and%20WHO%20group-A%20anti-1%20tuberculosis%20drugs.pdf},
HAL_ID = {hal-03481137},
HAL_VERSION = {v1},
}